These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37371948)

  • 1. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
    Lee J; Roh JL
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of FSP1: A new strategy for the treatment of tumors (Review).
    Dai Q; Wei X; Zhao J; Zhang D; Luo Y; Yang Y; Xiang Y; Liu X
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase separation of FSP1 promotes ferroptosis.
    Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
    Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis.
    Hendricks JM; Doubravsky CE; Wehri E; Li Z; Roberts MA; Deol KK; Lange M; Lasheras-Otero I; Momper JD; Dixon SJ; Bersuker K; Schaletzky J; Olzmann JA
    Cell Chem Biol; 2023 Sep; 30(9):1090-1103.e7. PubMed ID: 37178691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
    Nakamura T; Mishima E; Yamada N; Mourão ASD; Trümbach D; Doll S; Wanninger J; Lytton E; Sennhenn P; Nishida Xavier da Silva T; Angeli JPF; Sattler M; Proneth B; Conrad M
    Nat Struct Mol Biol; 2023 Nov; 30(11):1806-1815. PubMed ID: 37957306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
    Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
    Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous regulation of ferroptosis suppressor protein 1 and glutathione peroxidase 4 as a new therapeutic strategy of ferroptosis for esophageal squamous cell carcinoma.
    Miyauchi W; Shishido Y; Matsumi Y; Matsunaga T; Makinoya M; Shimizu S; Miyatani K; Sakamoto T; Umekita Y; Hasegawa T; Fujiwara Y
    Esophagus; 2023 Jul; 20(3):492-501. PubMed ID: 36576648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
    Mishima E; Ito J; Wu Z; Nakamura T; Wahida A; Doll S; Tonnus W; Nepachalovich P; Eggenhofer E; Aldrovandi M; Henkelmann B; Yamada KI; Wanninger J; Zilka O; Sato E; Feederle R; Hass D; Maida A; Mourão ASD; Linkermann A; Geissler EK; Nakagawa K; Abe T; Fedorova M; Proneth B; Pratt DA; Conrad M
    Nature; 2022 Aug; 608(7924):778-783. PubMed ID: 35922516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temsirolimus inhibits FSP1 enzyme activity to induce ferroptosis and restrain liver cancer progression.
    Tian RL; Wang TX; Huang ZX; Yang Z; Guan KL; Xiong Y; Wang P; Ye D
    J Mol Cell Biol; 2024 Sep; ():. PubMed ID: 39313331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ferroptosis suppressor protein 1 in cancer therapy: Implications and perspectives, with emphasis on head and neck cancer.
    Roh JL
    Crit Rev Oncol Hematol; 2024 Oct; 202():104440. PubMed ID: 38986728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into FSP1 catalysis and ferroptosis inhibition.
    Lv Y; Liang C; Sun Q; Zhu J; Xu H; Li X; Li YY; Wang Q; Yuan H; Chu B; Zhu D
    Nat Commun; 2023 Sep; 14(1):5933. PubMed ID: 37739943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of human ferroptosis suppressive protein 1 in complex with flavin adenine dinucleotide and nicotinamide adenine nucleotide.
    Feng S; Huang X; Tang D; Liu X; Ouyang L; Yang D; Wang K; Liao B; Qi S
    MedComm (2020); 2024 Mar; 5(3):e479. PubMed ID: 38414669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Intervention Nanoparticles for Triple-Negative Breast Cancer Therapy via Overcoming FSP1-Mediated Ferroptosis Resistance.
    Yang J; Jia Z; Zhang J; Pan X; Wei Y; Ma S; Yang N; Liu Z; Shen Q
    Adv Healthc Mater; 2022 Jul; 11(13):e2102799. PubMed ID: 35395704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing.
    Pontel LB; Bueno-Costa A; Morellato AE; Carvalho Santos J; Roué G; Esteller M
    Redox Biol; 2022 Sep; 55():102408. PubMed ID: 35944469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
    Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSP1: a key regulator of ferroptosis.
    Li W; Liang L; Liu S; Yi H; Zhou Y
    Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
    Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
    Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.